TReating Incontinence for Underlying Mental and Physical Health
Status:
Not yet recruiting
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed to
compare the effects of anticholinergic bladder therapy versus a) beta-3-adrenergic agonist
bladder therapy and b) no bladder pharmacotherapy on cognitive, urinary, and other
aging-related functional outcomes in ambulatory older women with urgency-predominant urinary
incontinence and either normal or mildly impaired cognitive function at baseline.